US equities |
TSLA $391.62 ▲+5.21% MU $903.70 ▲+2.98% META $630.56 ▼-1.88% NVDA $216.00 ▲+2.39% AAPL $343.91 ▼-1.10% SPCX $146.90 ▼-0.40% MSFT $532.60 ▲+1.54% AMD $531.28 ▲+2.80%
FinancialContent

Latest News about Fragile X Syndrome

Recent news which mentions Fragile X Syndrome

Psychedelics And The Spectrum: Groundbreaking Study Details How One Firm Approaches Autism
Tickers NMLSF
Tags Contracts Penny Stocks Top Stories
From Benzinga
Health Canada Grants Exemption: Phase 2 Trial On Psilocybin For Genetic Disorder
Tickers KONEF NMLSF
Tags Market News News Cannabis
From Benzinga
First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval
Tickers KONEF NMLSF
Tags Markets Benzinga Fragile X Syndrome
From Benzinga